Literature DB >> 19151383

Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.

Ludwig M Heindl1, Tanja N Hofmann, Harald L J Knorr, Carmen Rummelt, Falk Schrödl, Ursula Schlötzer-Schrehardt, Leonard M Holbach, Gottfried O H Naumann, Friedrich E Kruse, Claus Cursiefen.   

Abstract

PURPOSE: To analyze whether lymphatic vessels can invade the normally alymphatic eye (lymphangiogenesis) in patients with malignant melanoma of the ciliary body with extraocular extension and to correlate these findings with metastasis-free survival.
METHODS: Ten enucleated globes with the histopathologically and immunohistochemically (S-100, HMB-45, PNL-2, and Melan-A) confirmed diagnosis of malignant melanoma of the ciliary body with extraocular extension were matched with 10 globes with a ciliary body melanoma without extraocular extension regarding tumor size, cell type, melanin content, mitotic count, vascular networks, and patients' age. In all 20 cases, immunohistochemistry was performed to identify lymphatic vessels by using LYVE-1 and podoplanin as specific markers for lymphatic vascular endothelium.
RESULTS: Intraocular LYVE-1(+) and podoplanin(+) lymphatic vessels were detected in 7 of 10 malignant melanomas of the ciliary body with extraocular extension (two of these developed a regional lymph node metastasis). Lymphatic vessels were found only at the tumor periphery directly adjacent to the sclera within the eye, more often in tumors of the epithelioid type (P = 0.017, Mann-Whitney test). Ciliary body melanomas without extrascleral extension revealed no intraocular LYVE-1(+) and podoplanin(+) lymphatic vessels. The presence of intraocular LYVE-1(+)/podoplanin(+) lymphatic vessels was significantly associated with lower metastasis-free survival rates (P = 0.038, log-rank test).
CONCLUSIONS: Malignant melanomas of the ciliary body with extraocular extension show intraocular lymphatic vessels. This first evidence of lymphangiogenesis into the normally alymphatic eye may explain the increased risk of lymphatic metastasis in ciliary body melanoma with extraocular extension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151383     DOI: 10.1167/iovs.08-2935

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  [Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva].

Authors:  C Cursiefen
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

2.  Lack of ciliary body lymphatics in iridociliary melanocytoma.

Authors:  Ludwig M Heindl; Franziska Bucher; Gottfried O H Naumann; Claus Cursiefen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-10       Impact factor: 3.117

Review 3.  [Antiangiogenic therapy at the ocular surface: when, what and why?].

Authors:  F Bock; B Regenfuss; C Cursiefen
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

Review 4.  Consensus statement on the immunohistochemical detection of ocular lymphatic vessels.

Authors:  Falk Schroedl; Alexandra Kaser-Eichberger; Simona L Schlereth; Felix Bock; Birgit Regenfuss; Herbert A Reitsamer; Gerard A Lutty; Kazuichi Maruyama; Lu Chen; Elke Lütjen-Drecoll; Reza Dana; Dontscho Kerjaschki; Kari Alitalo; Maria Egle De Stefano; Barbara M Junghans; Ludwig M Heindl; Claus Cursiefen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-14       Impact factor: 4.799

5.  [Masquerades and Trojans : When tumors disguise as uveitis].

Authors:  R S Grajewski; L M Heindl
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

Review 6.  Immunotherapy for uveal melanoma.

Authors:  Dae Won Kim; Jaime Anderson; Sapna P Patel
Journal:  Melanoma Manag       Date:  2016-05-19

7.  Intra-ocular melanoma metastatic to an axillary lymph node: a case report.

Authors:  Nirupama Anne; Ratnakishore Pallapothu
Journal:  World J Surg Oncol       Date:  2011-05-27       Impact factor: 2.754

Review 8.  Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma.

Authors:  Joel M Mor; Ludwig M Heindl
Journal:  Ocul Oncol Pathol       Date:  2016-12-08

Review 9.  Ocular lymphatics: state-of-the-art review.

Authors:  L Chen
Journal:  Lymphology       Date:  2009-06       Impact factor: 1.286

Review 10.  Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis.

Authors:  Simona L Schlereth; Nasrin Refaian; Sandra Iden; Claus Cursiefen; Ludwig M Heindl
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.